MASON INDUSTRIAL TECHNOLOGY, INC.
NOTES TO CONDENSED FINANCIAL STATEMENTS
(Unaudited)
If the Company holds a stockholder vote or there is a tender offer for shares in connection
with an initial Business Combination, a public stockholder will have the right to redeem its shares for an amount in cash equal to its pro rata share of the aggregate amount then on deposit in the Trust Account as of two business days prior to the
consummation of the initial Business Combination, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay the Companys taxes.
Pursuant to the Companys amended and restated certificate of incorporation, if the Company is unable to complete the initial Business
Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than ten business days thereafter, redeem the Public Shares, at
a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the
Company to pay the Companys taxes (less $100,000 to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders rights as stockholders (including the
right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Companys remaining stockholders and the
Companys board of directors, dissolve and liquidate, subject in each case to the Companys obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.
The Sponsor and the Companys directors, director nominees and officers have entered into a letter agreement with the Company, pursuant
to which they have agreed to waive their rights to liquidating distributions from the Trust Account with respect to any Founder Shares (as defined below in Note 6, Related Party Transactions) held by them if the Company fails to complete an
initial Business Combination within the Combination Period. However, if the Sponsor or any of the Companys directors, officers or affiliates acquires shares of Class A common stock in or after the IPO, they will be entitled to liquidating
distributions from the Trust Account with respect to such shares if the Company fails to complete the initial Business Combination within the Combination Period.
Separate trading of Class A common shares and Public Warrants
On March 18, 2021, the Company announced that, commencing March 22, 2021, the holders of the Companys Units may elect to separately trade
the Class A common stock and Public Warrants comprising the Units. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Those units not separated will continue to trade on the New York Stock Exchange
under the symbol MIT.U, and each of the shares of Class A common stock and Public Warrants that are separated will trade on the New York Stock Exchange under the symbols MIT and MIT.W, respectively.
NOTE 2 RESTATEMENT OF A PREVIOUSLY ISSUED FINANCIAL STATEMENT
On April 12, 2021, the Acting Director of the Division of Corporation Finance and Acting Chief Accountant of the U.S. Securities and Exchange
Commission (the SEC) together issued a statement regarding the accounting and reporting considerations for warrants issued by special purpose acquisition companies entitled Staff Statement on Accounting and Reporting Considerations
for Warrants Issued by Special Purpose Acquisition Companies (SPACs) (the SEC Statement). Specifically, the SEC Statement focused on certain settlement terms and provisions related to certain tender offers following a
business combination, which terms are similar to those contained in the warrant agreement governing the Companys warrants. As a result of the SEC Statement, the Company reevaluated the accounting treatment of (i) the 16,666,667 Public
Warrants, (ii) the 8,813,334 Private Placement Warrants, and (iii) the 8,000,000 FPA Units. The Company previously accounted for the Warrants as components of equity and did not record anything for the FPA Units.
In further consideration of the guidance in Accounting Standards Codification (ASC) 480, Distinguishing Liabilities from
Equity (ASC 480), ASC 815, Derivatives and Hedging (ASC 815), and more specifically ASC 815-40, Derivatives and Hedging Contracts in Entitys Own Equity (ASC 815-40), the Company
concluded that certain provisions in the warrant agreement related to certain tender or exchange offers that preclude the Warrants from being accounted for as components of equity. The FPA was also determined to be a derivative instrument due to
similar settlement features of the Private Placement Warrants included in the FPA. As the Warrants and FPA Units meet the definition of a derivative as contemplated in ASC 815, the Warrants and FPA Units should have been recorded as derivative
liabilities on the balance sheet and measured at fair value at inception (on the date of the IPO) and at each reporting date in accordance with ASC 820, Fair Value Measurement, with changes in fair value recognized in the statement of
operations in the period of change. See Notes 3 and 4 for more information on the accounting for the Warrants and FPA Units and Note 6 for more information on the FPA.
Further, as a result of the classification of the Warrants as derivative liabilities and in accordance with ASC 470-20, Debt with
Conversion and Other Options (ASC 470-20), applied by analogy, the Company expensed a portion of the offering costs originally recorded as a reduction in equity. See Note 3 for more information on the allocation of issuance costs.
The Companys accounting for the warrants as components of equity instead of as derivative liabilities and not assigning a value to
the FPA did not have any effect on the Companys previously reported cash.
The following table summarizes the effect of the restatement on each impacted financial statement line item as of February 2, 2021:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As Previously Reported
|
|
|
Adjustment
|
|
|
As Restated
|
|
Balance Sheet as of February 2, 2021 (audited)
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivative warrant liabilities
|
|
$
|
|
|
|
$
|
36,720,001
|
|
|
$
|
36,720,001
|
|
Derivative forward purchase agreement liability
|
|
|
|
|
|
|
327,414
|
|
|
|
327,414
|
|
Total liabilities
|
|
|
17,807,378
|
|
|
|
37,047,415
|
|
|
|
54,854,793
|
|
Class A common stock subject to redemption
|
|
|
480,267,590
|
|
|
|
(37,047,410
|
)
|
|
|
443,220,180
|
|
Class A Common stock
|
|
|
197
|
|
|
|
371
|
|
|
|
568
|
|
Additional paid-in capital
|
|
|
5,081,895
|
|
|
|
1,320,977
|
|
|
|
6,402,872
|
|
Accumulated Deficit
|
|
|
(83,334
|
)
|
|
|
(1,321,353
|
)
|
|
|
(1,404,687
|
)
|
NOTE 3 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of presentation
The
accompanying unaudited interim condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (GAAP) for interim financial information and should be read in
conjunction with the Companys financial statements, summary of significant accounting policies and footnotes included in the Companys Annual Report on Form 10-K for the year ended December 31,
2020 (the 2020 Form 10-K). Accordingly, certain disclosures required by GAAP and normally included in Annual Reports on Form 10-K have been condensed or
omitted from this report; however, except as disclosed herein, there has been no material change in the information disclosed in the notes to condensed financial statements included in the Companys 2020 Form
10-K.
It is the opinion of management that all adjustments, consisting of normal recurring
adjustments considered necessary for a fair presentation of interim financial information, have been included. The Company has no items of other comprehensive income or loss; therefore, its net income or loss is identical to its comprehensive income
or loss. Operating results for the periods presented are not necessarily indicative of expected results for the full year or for any future interim periods.
Use of Estimates
In the course of
preparing the condensed financial statements, management makes various assumptions, judgments and estimates to determine the reported amounts of assets, liabilities, income and expenses, and in the disclosures of commitments and contingencies.
Changes in these assumptions, judgments and estimates will occur as a result of the passage of time and the occurrence of future events. Although management believes these estimates are reasonable, actual results could differ from these estimates.
Estimates made in preparing these condensed financial statements include, among other things, (1) the measurement of derivative
warrant liabilities, (2) the measurement of the derivative forward purchase agreement and (3) accrued expenses. Changes in these estimates and assumptions could have a significant impact on results in future periods.
Cash and cash equivalents
The
Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of March 31, 2021 and December 31, 2020.
7